Expert Interview
A Second Opinion: Examining Edgewise Therapeutics Phase 2 CIRRUS-HCM Clinical Trial Data on EDG-7500 for Hypertrophic Cardiomyopathy
Ticker(s): EWTX, CYTK, BMSInstitution: The Christ Hospital
Advanced Heart Failure & Transplant Cardiologist at The Christ Hospital in Cinncinnati, OH
Manages 20+ patients with Hypertrophic Cardiomyopathy
Co-Director of the Hypertrophic Cardiomyopathy Clinic and serves as a Principal Investigator on numerous HCM-related trials
What is the current standard of care for HCM?
Added By: ben_adminWhat are your impressions of the Phase 2 data on EDG-7500?
Added By: ben_adminHow concerning are the side effects seen in the phase 2 data?
Added By: ben_adminDescribe your background and practice setting
Added By: ben_adminHow many patients with oHCM do you manage?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
